Beverley Shields
Overview
Explore the profile of Beverley Shields including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
49
Citations
7879
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Alarcon G, Nguyen A, Jones A, Shields B, Redondo M, Tosur M
J Clin Endocrinol Metab
. 2024 Nov;
PMID: 39492690
Context: The applicability of the MODY risk calculator (Shields et al) to non- White European populations remains unknown. Objective: We aimed to test its real-world application in Hispanic youth. Methods:...
2.
Balungi P, Niwaha A, Nice R, Rodgers L, Mubiru N, Mukasa R, et al.
Pan Afr Med J
. 2024 Jul;
48:10.
PMID: 38946743
Introduction: the utility of glycated haemoglobin (HbA1c) for the diagnosis and monitoring of diabetes in sub-Saharan Africa is uncertain due to limited data on the performance of the available HbA1c...
3.
Association of birthweight and penetrance of diabetes in individuals with HNF4A-MODY: a cohort study
Locke J, Dusatkova P, Colclough K, Hughes A, Dennis J, Shields B, et al.
Diabetologia
. 2021 Oct;
65(1):246-249.
PMID: 34618178
No abstract available.
4.
Angwin C, Jenkinson C, Jones A, Jennison C, Henley W, Farmer A, et al.
BMJ Open
. 2020 Dec;
10(12):e042784.
PMID: 33371044
Introduction: Pharmaceutical treatment options for patients with type 2 diabetes mellitus (T2DM) have increased to include multiple classes of oral glucose-lowering agents but without accompanying guidance on which of these...
5.
Peters J, Anderson R, Shields B, King S, Hudson M, Shepherd M, et al.
BMJ Open
. 2020 Mar;
10(3):e034716.
PMID: 32193268
Objectives: To evaluate and compare the lifetime costs associated with strategies to identify individuals with monogenic diabetes and change their treatment to more appropriate therapy. Design: A decision analytical model...
6.
Lynam A, McDonald T, Hill A, Dennis J, Oram R, Pearson E, et al.
BMJ Open
. 2019 Sep;
9(9):e031586.
PMID: 31558459
Objective: To develop and validate multivariable clinical diagnostic models to assist distinguishing between type 1 and type 2 diabetes in adults aged 18-50. Design: Multivariable logistic regression analysis was used...
7.
Korevaar T, Derakhshan A, Taylor P, Meima M, Chen L, Bliddal S, et al.
JAMA
. 2019 Aug;
322(7):632-641.
PMID: 31429897
Importance: Maternal hypothyroidism and hyperthyroidism are risk factors for preterm birth. Milder thyroid function test abnormalities and thyroid autoimmunity are more prevalent, but it remains controversial if these are associated...
8.
Langendam M, Scholten R, Noel-Storr A, Thomas J, Marshall I, Wallace B, et al.
Diagn Progn Res
. 2019 May;
1:11.
PMID: 31095132
[This corrects the article DOI: 10.1186/s41512-016-0001-y.].
9.
Shields B, Colclough K
Diabetologia
. 2017 Jan;
60(4):609-612.
PMID: 28132100
MODY is an early-onset monogenic form of diabetes. Correctly identifying MODY is of considerable importance as diagnosing the specific genetic subtype can inform the optimal treatment, with many patients being...
10.
Misra S, Shields B, Colclough K, Johnston D, Oliver N, Ellard S, et al.
Diabetologia
. 2016 Jul;
59(10):2262-5.
PMID: 27435864
No abstract available.